GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Price-to-Operating-Cash-Flow

CLS Holdings USA (XCNQ:CLSH) Price-to-Operating-Cash-Flow : 2.76 (As of Apr. 29, 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Price-to-Operating-Cash-Flow?

As of today (2024-04-29), CLS Holdings USA's share price is C$0.08. CLS Holdings USA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.03. Hence, CLS Holdings USA's Price-to-Operating-Cash-Flow Ratio for today is 2.76.

The historical rank and industry rank for CLS Holdings USA's Price-to-Operating-Cash-Flow or its related term are showing as below:

XCNQ:CLSH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.02   Med: 1.53   Max: 3.04
Current: 2.57

During the past 11 years, CLS Holdings USA's highest Price-to-Operating-Cash-Flow Ratio was 3.04. The lowest was 1.02. And the median was 1.53.

XCNQ:CLSH's Price-to-Operating-Cash-Flow is ranked better than
96.15% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.435 vs XCNQ:CLSH: 2.57

CLS Holdings USA's Cash Flow from Operations per share for the three months ended in Feb. 2024 was C$-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 65.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 47.20% per year.

During the past 11 years, CLS Holdings USA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 65.80% per year. The lowest was -257.30% per year. And the median was 24.00% per year.


CLS Holdings USA Price-to-Operating-Cash-Flow Historical Data

The historical data trend for CLS Holdings USA's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Price-to-Operating-Cash-Flow Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.68 1.01 2.36

Competitive Comparison of CLS Holdings USA's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Price-to-Operating-Cash-Flow falls into.



CLS Holdings USA Price-to-Operating-Cash-Flow Calculation

CLS Holdings USA's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.08/0.029
=2.76

CLS Holdings USA's Share Price of today is C$0.08.
CLS Holdings USA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

CLS Holdings USA Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.